Markets shrug off Grexit fears; Nifty ends above 8,500

The recovery in late trades was led by pharma shares and index heavyweights

Tulemino Antao Mumbai
Last Updated : Jul 06 2015 | 5:20 PM IST
Benchmark shares indices staged a recovery in late trades, shrugging off the developments in Greece, led by pharma shares and index heavyweights while TCS gained ahead of its first quarter results this week.

The 30-share Sensex ended 116 points at 28,209 and the Nifty ended up 37 points at 8,522.

"We have been quite vocal about market presenting a buying opportunity whenever any adverse news from Greece flows in. We are more or less insulated from the proceedings in Greece with Strong foreign exchange reserves, improving macros  & crude again heading southwards. Manufacturing growth seems to have bottomed out; we are seeing signs of normalization in industry. For our markets, the Q1 Earnings season, progress of the monsoon & Monsoon Session of the Parliament are likely to be key triggers. Rising equity allocation in domestic savings is also supporting the equity market. Our view is that, Investors should utilize all such dips lead by fear factors to accumulate good quality businesses," said Devang Mehta, Sr.VP & Head – Equity Advisory, AnandRathi Financial Services.

The broader market outperformed the benchmarks. The BSE Midcap and Smallcap indices ended up 0.9-1.1% each.

Market breadth ended strong with 1,788 gainers and 1,008 losers on the BSE.

The Indian rupee recouped intra-day losses and was trading unchanged at 63.44 against the US dollar on fresh dollar tracking recovery in domestic equities.

EVENTS OF THE WEEK

The first quarter earnings season will kick off with Tata Consultancy Services announcing it April-June results on Thursday.

Index of Industrial Production (IIP) data for the month of May is scheduled to be released on Friday.

GLOBAL TRENDS

Post the announcement of the referendum results, Greece's Finance Minister Yanis Varoufakis said he was resigning, in a shock announcement despite the government having secured a resounding victory for the 'No' vote in the country's referendum on bailout conditions

China's benchmark Shanghai Composite ended up 2.4% after market participants such as brokerages and fund managers offeres to buy huge quantities of stocks to bring out stability.

SECTORS & STOCKS

BSE Healthcare index was the top gainer up 1.7% followed by Oil & Gas and Realty indices followed by others. Consumer Durables and Metal indices were among the top losers.

According to PTI reports, the government has taken several measures, including setting up of an inter-departmental committee to look into export-related issues and awareness programmes in emerging markets like Africa, to boost pharmaceutical exports. Dr Reddy's Labs, Cipla, Sun Pharma and Lupin ended up 1.4-3.7% each.

Among the index heavyweights, Reliance Industries gained 1.1% while ITC ended up 0.9%.

In the banking pack, ICICI Bank, HDFC Bank and SBI ended up 0.5-1% each.

Metal stocks witnessed selling as softening commodity prices compounding worries about oversupply, after Greece rejected terms for a bailout. Vedanta, and Hindalco ended down between 1.6-4.7% each.

In the IT space, Infosys ended down 0.7% and Wipro eased 0.3%. TCS recouped intra-day losses to end 1% higher ahead of its Q1 results due on Thursday.

VA Tech Wabag ended up 2.5% after the company along with their joint venture (JV) partner, Belhasa Projects, won an EPC order in the water and waste water treatment space in the Kingdom of Bahrain.

Arvind Remedies ended locked in 20% upper circuit after the board said it would meet on July 11 to consider proposal for investment in the company by a potential investor to make the unit viable.

Tilaknagar Industries ended up 20% on reports that the Kishore Chhabria-controlled Allied Blenders & Distillers (ABD) has entered the final round of negotiations to acquire a controlling stake in the company.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 06 2015 | 3:49 PM IST

Next Story